Eye to the Future in Adenomyosis Research

Seminars in Reproductive Medicine - Tập 38 Số 02/03 - Trang 197-200 - 2020
Lisa M. Halvorson1, Linda C. Giudice2, Elizabeth A. Stewart3
1Gynecologic Health and Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland
2Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California
3Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota

Tóm tắt

AbstractAdenomyosis is a poorly understood and clinically underappreciated gynecologic disorder associated with substantial morbidity including dysmenorrhea, pelvic pain, heavy menstrual bleeding, infertility, and poor pregnancy outcomes. Substantial gaps persist in our understanding of essentially all aspects of this disorder – epidemiology, risk factors, pathogenesis, pathophysiology, diagnosis, and treatment. In this article, we summarize current thoughts on future directions in basic, translational, and clinical adenomyosis research.

Từ khóa


Tài liệu tham khảo

H S Taylor, 2017, Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist, N Engl J Med, 377, 28, 10.1056/NEJMoa1700089

P A Rogers, 2017, Research Priorities for Endometriosis, Reprod Sci, 24, 202, 10.1177/1933719116654991

E A Stewart, 2018, The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design, Am J Obstet Gynecol, 219, 95e1, 10.1016/j.ajog.2018.05.004

S Vannuccini, 2019, Recent advances in understanding and managing adenomyosis, F1000 Res, 8, 8, 10.12688/f1000research.17242.1

J Zhai, 2020, Adenomyosis: mechanisms and pathogenesis, Semin Reprod Med, 38, 129, 10.1055/s-0040-1716687

C C Yeh, 2018, Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study, PLoS One, 13, e0194011, 10.1371/journal.pone.0194011

S Guo, 2018, GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity, Drug Des Devel Ther, 12, 1621, 10.2147/DDDT.S162541

M Razavi, 2019, Systematic review and meta-analysis of adverse pregnancy outcomes after uterine adenomyosis, Int J Gynaecol Obstet, 145, 149, 10.1002/ijgo.12799

M Habiba, 2018, Adenomyosis and Endometrial Cancer: Literature Review, Gynecol Obstet Invest, 83, 313, 10.1159/000487320

R Champaneria, 2010, Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy, Acta Obstet Gynecol Scand, 89, 1374, 10.3109/00016349.2010.512061

M Loring, 2020, Symptoms of adenomyosis and overlapping diseases, Semin Reprod Med, 38, 144, 10.1055/s-0040-1721795

A O'Shea, 2020, Imaging diagnosis of adenomyosis, Semin Reprod Med, 38, 119, 10.1055/s-0040-1719017

S Acar, 2016, Value of ultrasound shear wave elastography in the diagnosis of adenomyosis, Ultrasound, 24, 205, 10.1177/1742271X16673677

M F Antero, 2020, Pathology and pathogenesis of adenomyosis, Semin Reprod Med, 38, 108, 10.1055/s-0040-1718922

C N Herndon, 2016, Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis, Reprod Sci, 23, 1289, 10.1177/1933719116650758

M G Munro, 2020, Classification and Reporting Systems for Adenomyosis, J Minim Invasive Gynecol, 27, 296, 10.1016/j.jmig.2019.11.013

J YS Tsang, 2020, Molecular Classification of Breast Cancer, Adv Anat Pathol, 27, 27, 10.1097/PAP.0000000000000232

R Marquardt, 2020, Animal models of adenomyosis, Semin Reprod Med, 38, 170

J Gnecco, 2020, Physiomimetic models of adenomyosis, Semin Reprod Med, 38, 181

A G Cope, 2020, Current and future medical therapies for adenomyosis, Semin Reprod Med, 38, 153

J Chen, 2020, Current and future surgical and interventional management options for adenomyosis, Semin Reprod Med, 38, 159